Publication: Efficacy of oral micronized progesterone when applied via vaginal route
1
Issued Date
2004-05-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-2942564704
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.87, No.5 (2004), 455-458
Suggested Citation
Roungsin Choavaratana, Darapa Manoch Efficacy of oral micronized progesterone when applied via vaginal route. Journal of the Medical Association of Thailand. Vol.87, No.5 (2004), 455-458. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/21665
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Efficacy of oral micronized progesterone when applied via vaginal route
Author(s)
Other Contributor(s)
Abstract
The aim of the study was to compare the efficacy of oral micronized progesterone when applied by the vaginal route. The comparative study of serum progesterone levels between oral and vaginal micronized progesterone administration was conducted in sixty female volunteers. The subjects were equally divided into two groups to receive the drug either via the oral or vaginal route. The subjects' profiles showed that there was no significant difference in general characteristics between these two groups. The blood tests for estrogen and progesterone levels were performed on all volunteers before and after the drug administration. The data collected from the experiment revealed that the serum progesterone levels achieved by oral administration (5.06 ± 2.95 ng/ml) differed significantly (p < 0.001) from those achieved by vaginal administration (8.26 ± 4.09 ng/ml). The data also revealed that the serum progesterone levels of the oral administration group (4.23 ± 2.68 ng/ml) did not differ significantly (p = 0. 925) from the other group (4.15 ± 3.40 ng/ml) when the serum estrogen level was less than 30 pg/ml. On the contrary, when the serum estrogen level was at least 30 pg/ml, there was a significant (p < 0.005) difference in the serum progesterone levels between these two groups (6.32 ± 2.99 ng/ml for the oral route and 9.76 ± 3.23 ng/ml for the vaginal route).